OPKO Health (NASDAQ: OPK) saw its shares tumble 5.47% in after-hours trading on Thursday following the release of its second quarter 2025 financial results. The healthcare company reported a mixed bag of results, with significant losses and missed revenue targets overshadowing a better-than-expected adjusted earnings per share.

The company reported a staggering net loss of $148.4 million for the quarter, with an operating loss of $60 million. Revenue from services came in at $101.1 million, contributing to total sales of $156.8 million. This figure fell short of analyst expectations of $165.744 million, representing a 13.94% decrease compared to the same period last year. The basic earnings per share (EPS) stood at a loss of $0.19.

Despite the overall negative results, there were some silver linings. OPKO's adjusted EPS of $(0.07) beat the analyst consensus estimate of $(0.11) by 35.78%. Additionally, the company's board authorized an additional $100 million for stock repurchases, potentially signaling confidence in the company's long-term prospects. However, these positive notes were not enough to offset investor concerns about the company's financial performance, leading to the significant after-hours stock price decline.